Literature DB >> 24899502

Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells.

Smita S Ghare1, Swati Joshi-Barve2, Akshata Moghe3, Madhuvanti Patil3, David F Barker1, Leila Gobejishvili1, Guy N Brock4, Matthew Cave2, Craig J McClain2, Shirish S Barve5.   

Abstract

Activation-induced Fas ligand (FasL) mRNA expression in CD4+ T cells is mainly controlled at transcriptional initiation. To elucidate the epigenetic mechanisms regulating physiologic and pathologic FasL transcription, TCR stimulation-responsive promoter histone modifications in normal and alcohol-exposed primary human CD4+ T cells were examined. TCR stimulation of normal and alcohol-exposed cells led to discernible changes in promoter histone H3 lysine trimethylation, as documented by an increase in the levels of transcriptionally permissive histone 3 lysine 4 trimethylation and a concomitant decrease in the repressive histone 3 lysine 9 trimethylation. Moreover, acetylation of histone 3 lysine 9 (H3K9), a critical feature of the active promoter state that is opposed by histone 3 lysine 9 trimethylation, was significantly increased and was essentially mediated by the p300-histone acetyltransferase. Notably, the degree of these coordinated histone modifications and subsequent recruitment of transcription factors and RNA polymerase II were significantly enhanced in alcohol-exposed CD4+ T cells and were commensurate with the pathologic increase in the levels of FasL mRNA. The clinical relevance of these findings is further supported by CD4+ T cells obtained from individuals with a history of heavy alcohol consumption, which demonstrate significantly greater p300-dependent H3K9 acetylation and FasL expression. Overall, these data show that, in human CD4+ T cells, TCR stimulation induces a distinct promoter histone profile involving a coordinated cross-talk between histone 3 lysine 4 and H3K9 methylation and acetylation that dictates the transcriptional activation of FasL under physiologic, as well as pathologic, conditions of alcohol exposure.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899502      PMCID: PMC5096587          DOI: 10.4049/jimmunol.1400055

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Partitioning and plasticity of repressive histone methylation states in mammalian chromatin.

Authors:  Antoine H F M Peters; Stefan Kubicek; Karl Mechtler; Roderick J O'Sullivan; Alwin A H A Derijck; Laura Perez-Burgos; Alexander Kohlmaier; Susanne Opravil; Makoto Tachibana; Yoichi Shinkai; Joost H A Martens; Thomas Jenuwein
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

2.  The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme.

Authors:  Fabrizio Dal Piaz; Alessandra Tosco; Daniela Eletto; Anna L Piccinelli; Ornella Moltedo; Silvia Franceschelli; Gianluca Sbardella; Paolo Remondelli; Luca Rastrelli; Loredana Vesci; Claudio Pisano; Nunziatina De Tommasi
Journal:  Chembiochem       Date:  2010-04-12       Impact factor: 3.164

Review 3.  The dynamics of chromatin remodeling at promoters.

Authors:  Jane Mellor
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

4.  Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4.

Authors:  Michiel Vermeulen; Klaas W Mulder; Sergei Denissov; W W M Pim Pijnappel; Frederik M A van Schaik; Radhika A Varier; Marijke P A Baltissen; Henk G Stunnenberg; Matthias Mann; H Th Marc Timmers
Journal:  Cell       Date:  2007-09-20       Impact factor: 41.582

5.  Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.

Authors:  Jung S Byun; Madeline M Wong; Wenwu Cui; Gila Idelman; Quentin Li; Adriana De Siervi; Sven Bilke; Cynthia M Haggerty; Audrey Player; Yong Hong Wang; Michael J Thirman; Joseph J Kaberlein; Constantinos Petrovas; Richard A Koup; Dan Longo; Keiko Ozato; Kevin Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

6.  Ethanol inhibits lipid raft-mediated TCR signaling and IL-2 expression: potential mechanism of alcohol-induced immune suppression.

Authors:  Smita Ghare; Madhuvanti Patil; Prachi Hote; Jill Suttles; Craig McClain; Shirish Barve; Swati Joshi-Barve
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

7.  Alcohol use and alcohol-related problems before and after military combat deployment.

Authors:  Isabel G Jacobson; Margaret A K Ryan; Tomoko I Hooper; Tyler C Smith; Paul J Amoroso; Edward J Boyko; Gary D Gackstetter; Timothy S Wells; Nicole S Bell
Journal:  JAMA       Date:  2008-08-13       Impact factor: 56.272

Review 8.  The role of CD95 in the regulation of peripheral T-cell apoptosis.

Authors:  Andreas Krueger; Stefanie C Fas; Sven Baumann; Peter H Krammer
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

9.  Ethanol inhibits methionine adenosyltransferase II activity and S-adenosylmethionine biosynthesis and enhances caspase-3-dependent cell death in T lymphocytes: relevance to alcohol-induced immunosuppression.

Authors:  Prachi T Hote; Rashmita Sahoo; Tanvi S Jani; Smita S Ghare; Theresa Chen; Swati Joshi-Barve; Craig J McClain; Shirish S Barve
Journal:  J Nutr Biochem       Date:  2007-09-14       Impact factor: 6.048

10.  The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.

Authors:  José Manuel Afonso Moreira; Peter Scheipers; Poul Sørensen
Journal:  BMC Cancer       Date:  2003-11-09       Impact factor: 4.430

View more
  16 in total

1.  Premature termination codons in the DMD gene cause reduced local mRNA synthesis.

Authors:  Raquel García-Rodríguez; Monika Hiller; Laura Jiménez-Gracia; Zarah van der Pal; Judit Balog; Kevin Adamzek; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-02       Impact factor: 11.205

2.  Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.

Authors:  Smita S Ghare; Hridgandh Donde; Wei-Yang Chen; David F Barker; Leila Gobejishvilli; Craig J McClain; Shirish S Barve; Swati Joshi-Barve
Journal:  Toxicol In Vitro       Date:  2016-05-26       Impact factor: 3.500

3.  SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.

Authors:  James Ropa; Nirmalya Saha; Hsiangyu Hu; Luke F Peterson; Moshe Talpaz; Andrew G Muntean
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

4.  H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Authors:  Amy V Paschall; Dafeng Yang; Chunwan Lu; Jeong-Hyeon Choi; Xia Li; Feiyan Liu; Mario Figueroa; Nicholas H Oberlies; Cedric Pearce; Wendy B Bollag; Asha Nayak-Kapoor; Kebin Liu
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

5.  Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy.

Authors:  Luciano E Marasco; Gwendal Dujardin; Rui Sousa-Luís; Ying Hsiu Liu; Jose N Stigliano; Tomoki Nomakuchi; Nick J Proudfoot; Adrian R Krainer; Alberto R Kornblihtt
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850

6.  Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease.

Authors:  Leila Gobejishvili; Smita Ghare; Rehan Khan; Alexander Cambon; David F Barker; Shirish Barve; Craig McClain; Daniell Hill
Journal:  Clin Immunol       Date:  2015-09-25       Impact factor: 3.969

7.  Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.

Authors:  Satish Ranjan; Alexander Goihl; Shrey Kohli; Ihsan Gadi; Mandy Pierau; Khurrum Shahzad; Dheerendra Gupta; Fabian Bock; Hongjie Wang; Haroon Shaikh; Thilo Kähne; Dirk Reinhold; Ute Bank; Ana C Zenclussen; Jana Niemz; Tina M Schnöder; Monika Brunner-Weinzierl; Thomas Fischer; Thomas Kalinski; Burkhart Schraven; Thomas Luft; Jochen Huehn; Michael Naumann; Florian H Heidel; Berend Isermann
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

8.  Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death.

Authors:  Smita S Ghare; Paula M Chilton; Aakarsha V Rao; Swati Joshi-Barve; Paula Peyrani; Andrea Reyes Vega; Craig J McClain; Kendall Bryant; Robert L Cook; Mathew Freiberg; Shirish Barve
Journal:  J Acquir Immune Defic Syndr       Date:  2021-01-01       Impact factor: 3.771

9.  G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.

Authors:  Geoffroy Laumet; Judit Garriga; Shao-Rui Chen; Yuhao Zhang; De-Pei Li; Trevor M Smith; Yingchun Dong; Jaroslav Jelinek; Matteo Cesaroni; Jean-Pierre Issa; Hui-Lin Pan
Journal:  Nat Neurosci       Date:  2015-11-09       Impact factor: 24.884

Review 10.  Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition.

Authors:  Shirish Barve; Shao-Yu Chen; Irina Kirpich; Walter H Watson; Craig Mcclain
Journal:  Alcohol Res       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.